Free Trial

Cellmid (CDY) News Today

Hair Loss Products Market SWOT Analysis till 2030
Get Cellmid News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDY and its competitors with MarketBeat's FREE daily newsletter.

Why I'm telling friends to avoid gold stocks (Ad)

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.

CDY Media Mentions By Week

CDY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CDY
News Sentiment

0.00

0.61

Average
Medical
News Sentiment

CDY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CDY Articles
This Week

0

0

CDY Articles
Average Week

Get Cellmid News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (ASX:CDY) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners